Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News

Africa CDC to review use of AstraZeneca vaccine

William Ukpe by William Ukpe
March 16, 2021
in Business News, Coronavirus, Spotlight
Covid-19: African Union in talks with China and Russia over vaccine
Share on FacebookShare on TwitterShare on Linkedin

The Africa Centre for Disease Control has disclosed that it is reviewing the usage of the AstraZeneca vaccine which is being used in Africa for Covid-19 vaccinations under the COVAX programme.

This was disclosed by John Nkengasong, Director of Africa CDC in an interview with Bloomberg after reports emerged of European countries placing a pause on AstraZeneca vaccines due to reports of blood clots.

“The AstraZeneca vaccine was seen to be safe and efficacious and we would need to review the data. We should guide the response with strong science and evidence,” Nkengasong said.

RelatedPosts

Canada donates 2.6 million doses of COVID-19 vaccines to Nigeria

World Bank says COVID-19 sparked surge in financial inclusion globally

READ: Nigeria to get 41 million Covid-19 vaccines from African Union – NPHCDA

“The Africa CDC will be convening an emergency meeting this afternoon with all the experts across the continent to look at the data and what we know, and then to provide appropriate guidance to the continent,” he added.

News continues after this ad


On using the vaccines to slow the spread of the pandemic, the Africa CDC boss warned that it could take Africa 5 years to end the pandemic if vaccination pace remains slow citing that if Africa “vaccinates at least 60% of our population in the next two years, then this pandemic will be over”.

READ: Covid-19: NPHCDA to train over 12,000 health workers to administer vaccines

What you should know

  • Nairametrics reported that the National Primary Health Care Development Agency disclosed that it has not received any official report of serious adverse effects from any of those who have been vaccinated.
  • Ireland has suspended the use of the AstraZeneca vaccine over fears of alleged post-jab blood.
  • Germany, France and Italy announced on Monday they would suspend AstraZeneca COVID-19  vaccine disbursement after multiple countries reported possible serious side-effects. However, the  WHO said there was no proven link and people should not panic.

Related

Tags: Africa CDCAstraZeneca vaccineCovid-19

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

inq
avatrade
Stanbic bank
Mega Millions
UBN
Hot forex
Access Bank
Bankers Committee
First bank






    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Gains from MTN not enough to stop Nigeria’s stock market from shedding N95 billion
    • ChamsSwitch gets Visa recognition, enlisted on Visa Global Registry
    • 3 ways to solve electricity crisis in Nigeria – Atiku Abubakar

    Follow us on social media:

    Recent News

    Stock News

    Gains from MTN not enough to stop Nigeria’s stock market from shedding N95 billion

    August 19, 2022
    ChamsSwitch gets Visa recognition, enlisted on Visa Global Registry

    ChamsSwitch gets Visa recognition, enlisted on Visa Global Registry

    August 19, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com